These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21810233)

  • 21. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ; Shelton RC; Crits-Christoph P; Keller MB; Dunner DL; Hirschfeld RM; Thase ME; Russell JM; Lydiard RB; Gallop RJ; Todd L; Hellerstein DJ; Goodnick PJ; Keitner GI; Stahl SM; Halbreich U; Hopkins HS
    J Clin Psychiatry; 2004 Aug; 65(8):1114-9. PubMed ID: 15323598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers.
    Warren MB; Cowen PJ; Harmer CJ
    J Psychopharmacol; 2019 Feb; 33(2):194-201. PubMed ID: 30484733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. St John's wort greatly decreases the plasma concentrations of oral S-ketamine.
    Peltoniemi MA; Saari TI; Hagelberg NM; Laine K; Neuvonen PJ; Olkkola KT
    Fundam Clin Pharmacol; 2012 Dec; 26(6):743-50. PubMed ID: 21635359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
    Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
    Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of St John's wort on imatinib mesylate pharmacokinetics.
    Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
    Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
    Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
    Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults.
    Diaper A; Hindmarch I
    Phytother Res; 2004 Oct; 18(10):831-6. PubMed ID: 15551388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
    Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
    Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
    Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valerian extract alters functional brain connectivity: A randomized double-blind placebo-controlled trial.
    Roh D; Jung JH; Yoon KH; Lee CH; Kang LY; Lee SK; Shin K; Kim DH
    Phytother Res; 2019 Apr; 33(4):939-948. PubMed ID: 30632220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
    Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
    J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of St John's wort on severity, frequency, and duration of hot flashes in premenopausal, perimenopausal and postmenopausal women: a randomized, double-blind, placebo-controlled study.
    Abdali K; Khajehei M; Tabatabaee HR
    Menopause; 2010 Mar; 17(2):326-31. PubMed ID: 20216274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA; Metzler CW; Mirescu C; Stein SK; Jacobs BL
    Neuropsychopharmacology; 2001 Dec; 25(6):858-70. PubMed ID: 11750179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
    Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
    Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.
    Stage TB; Pedersen RS; Damkier P; Christensen MM; Feddersen S; Larsen JT; Højlund K; Brøsen K
    Br J Clin Pharmacol; 2015 Feb; 79(2):298-306. PubMed ID: 25223504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The recovery time-course of CYP3A after induction by St John's wort administration.
    Imai H; Kotegawa T; Tsutsumi K; Morimoto T; Eshima N; Nakano S; Ohashi K
    Br J Clin Pharmacol; 2008 May; 65(5):701-7. PubMed ID: 18294328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Source density analysis of functional topographical EEG: monitoring of cognitive drug action.
    Dimpfel W; Hofmann HC; Prohaska A; Schober F; Schellenberg R
    Eur J Med Res; 1996 Mar; 1(6):283-90. PubMed ID: 9367941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.